Our results emphasize the balance between IFNα and TNFα in RA, and provide mechanistic insights into the possible roles of DC subsets in mediating the shift in autoimmune disease manifestations by therapeutics that inhibit TNFα. Here, IFNA1 is linked to autoimmune disease.